Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Hikal Limited

HIKAL.NSNSE
Healthcare
Drug Manufacturers - Specialty & Generic
201.52
0.96(0.48%)
Indian Market opens in 12h 37m

Hikal Limited (HIKAL.NS) Stock Overview

Explore Hikal Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap24.8B
P/E Ratio-190.54
EPS (TTM)$-1.06
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$265.77
3 Months$293.72
1 Year Target$316.49

HIKAL.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hikal Limited (HIKAL.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $316.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -190.54 and a market capitalization of 24.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.16%
5-Day Change
-0.99%
1-Month Change
3.25%
3-Month Change
-10.61%
6-Month Change
-21.74%
Year-to-Date (YTD) Change
-11.47%
1-Year Change
-41.43%
3-Year Change
-32.60%
5-Year Change
25.75%
All-Time (Max) Change
1973.17%

Contact Information

91 22 3097 3100
Great Eastern Chambers, Navi Mumbai, NaN, 400614

Company Facts

20,610 Employees
IPO DateJul 1, 2002
CountryIN
Actively Trading

Frequently Asked Questions